Dysfunction in Multiple Primary Afferent Fiber Subtypes Revealed By Quantitative Sensory Testing in Patients with Chronic Vincristine-Induced Pain

Journal of Pain and Symptom Management

Volumn 33, Issue 2, 2007, Pages 166-179

  Dougherty, Patrick M ^a   Cata, Juan P ^a   Burton, Allen W ^a   Vu, Khanh ^a   Weng, Han Rong ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; chemotherapy; human; hyperalgesia

Indexed keywords

AMITRIPTYLINE; CODEINE; DULOXETINE; ETIRACETAM; FENTANYL; GABAPENTIN; HYDROMORPHONE; METHADONE; MORPHINE; NORTRIPTYLINE; OMEGA CONOTOXIN MVIIA; OPIATE; OXYCODONE; PACLITAXEL; PARACETAMOL; TIZANIDINE; TOPIRAMATE; TRAMADOL; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; ZONISAMIDE;

ADULT; ARTICLE; BURNING SENSATION; CANCER CHEMOTHERAPY; CHRONIC PAIN; COLD TREATMENT; CONTROLLED STUDY; COOLING; DRUG SAFETY; FEMALE; HEAT INJURY; HUMAN; HYPERALGESIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PAIN; PAIN ASSESSMENT; PARESTHESIA; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; SENSORY DYSFUNCTION; SKIN PAIN; SKIN REDNESS; SKIN TINGLING; TOUCH;

ADULT; AFFERENT PATHWAYS; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; VINCRISTINE;

EID: 33846571392     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.08.006     Document Type: Article

References (42)

1. Connors J.M. Hodgkin's lymphoma. In: Abeloff M.D., Armitage J.O., Niederhuber J.E., Kastan M.B., and McKenna W.G. (Eds). Clinical oncology. 3rd ed. (2004), Elsevier, New York 2985-3014
2. Koeppen S., Verstappen C.C.P., Körte R., et al. Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma. J Cancer Res Clin Oncol 130 (2004) 153-160
3. Calhoun E.A., Chang C.H., Welshman E.E., et al. Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist 6 (2001) 441-445
4. Holland J.F., Scharlau C., Gailani S., et al. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 33 (1973) 1258-1264
5. Klasa R.J., Meyer R.M., Shustik C., et al. Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen. J Clin Oncol 20 (2002) 4649-4654
6. Postma T.J., Benard B.A., Huijgens P.C., Ossenkoppele G.J., and Heimans J.J. Long term effects of vincristine on the peripheral nervous system. J Neurooncol 15 (1993) 23-27
7. Chauvenet A.R., Shashi A., Selsky C., et al. Vincristine-induced neuropathy as the initial presentation of a Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J Pediatr Hematol Oncol 25 (2003) 316-320
8. Cassady J.R., Tonnesen G.L., Wolfe L.C., and Sallan S.E. Augmentation of vincristine neurotoxicity by irradiation of peripheral nerves. Cancer Treat Rep 64 (1980) 963-965
9. Roca E., Bruera E., Politi P.M., et al. Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat Rep 69 (1985) 149-151
10. Dougherty P.M., Cata J.P., Cordella J.V., Burton A., and Weng H.-R. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109 (2004) 132-142
11. Lenz F.A., and Dougherty P.M. Neurons in the human thalamic principal somatosensory nucleus (ventralis caudalis, Vc) respond to innocuous cool and mechanical stimuli. J Neurophysiol 79 (1998) 2227-2230
12. Gracely R.H., McGrath P., and Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 5 (1978) 19-29
13. Fuchs P.N., Campbell J.N., and Meyer R.A. Secondary hyperalgesia persists in capsaicin desensitized skin. Pain 84 (2000) 141-149
14. Schmidt S.L., Oliveira R.M., Rocha F.R., and Abreu-Villaça Y. Influence of handedness and gender on the grooved pegboard test. Brain Cogn 44 (2000) 445-454
15. Hansen S.W., Helweg-Larsen S., and Trojaborg W. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. J Clin Oncol 7 (1989) 1457-1461
16. Cata J.P., Weng H.-R., and Dougherty P.M. Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats. Cancer Chemother Pharmacol 54 (2004) 391-397
17. Rahman M., Griffin S.J., Rathmann W., and Wareham N.J. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med 20 (2003) 368-374
18. Wulff E.A., Wang A.K., and Simpson D.M. HIV-associated peripheral neuropathy. Drugs 59 (2000) 1251-1260
19. Sandler S.G., Tobin W., and Henderson E.S. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 19 (1969) 367-374
20. Casey E.B., Jellife A.M., Le Quesne P.M., and Millet Y.L. Vincristine neuropathy. Clinical and electrophysiological observations. Brain 96 (1973) 69-86
21. Verstappen C.C.P., Koeppen S., Heimans J.J., et al. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology 64 (2005) 1076-1077
22. Franse L.V., Valk G.D., Dekker J.H., Heine R.J., and van Eijk J.T.M. 'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients. Diabet Med 17 (2000) 105-110
23. Torebjörk H.E., Schady W., and Ochoa J. Sensory correlates of somatic afferent fibre activation. Hum Neurobiol 3 (1984) 15-20
24. Dyck P.J., and O'Brien P.C. Quantitative sensation testing in epidemiological and therapeutic studies of peripheral neuropathy. Muscle Nerve 22 (1999) 659-662
25. Dyck P.J., Karnes J.L., Daube J., O'Brien P.C., and Service F.J. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108 (1985) 861-880
26. Mackel R. Properties of cutaneous afferents in diabetic neuropathy. Brain 112 (1989) 1359-1376
27. Mizobuchi K., Kuwara S., Toma S., et al. Properties of human skin mechanoreceptors in peripheral neuropathy. Clin Neurophysiol 113 (2002) 310-315
28. Said G., Slama G., and Selva J. Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain 106 (1983) 791-807
29. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., and Standefer J.C. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54 (1984) 1269-1275
30. Adriaensen H., Gybels J., Handwerker H.O., and Van Hees J. Response properties of thin myelinated (A-delta) fibers in human skin nerves. J Neurophysiol 49 (1983) 111-122
31. Weng H.-R., Cordella J.V., and Dougherty P.M. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103 (2003) 131-138
32. Chan A.W., MacFarlane I.A., Bowsher D., and Campbell J.A. Weighted needle pinprick sensory thresholds: a simple test of sensory function in diabetic peripheral neuropathy. J Neurol Neurosurg Psychiatr 55 (1992) 56-59
33. Kramer H.H., Rolke R., Bickel A., and Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 27 (2004) 2386-2391
34. Benbow S.J., Chan A.W., Bowsher D., MacFarlane I.A., and Williams G. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 11 (1994) 17-21
35. Cavaletti G., Cavaletti E., Oggioni N., et al. Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology 21 (2000) 389-394
36. Tanner K.D., Reichling D.B., and Levine J.D. Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J Neurosci 18 (1998) 6480-6491
37. Tanner K.D., Levine J.D., and Topp K.S. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol 395 (1998) 481-492
38. Polomano R.C., Mannes A.J., Clark U.S., and Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94 (2001) 293-304
39. Ogawa T., Mimura Y., Ootsubo S., and Murakoshi M. The uselfuness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following the administration of vincristine. Neurotoxicol 21 (2000) 501-512
40. Thant M., Hawley R.J., Smith M.T., et al. Possible enhancement of vincristine neuropathy by VP-16. Cancer 49 (1982) 859-864
41. Djaldetti R., Hart J., Alexandrova S., et al. Vincristine-induced alterations in Schwann cells of mouse peripheral nerve. Am J Hematol 52 (1996) 254-257
42. Lynch I.I.I., Wade C.L., Zhong C.M., Mikusa J.P., and Honore P. Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 110 (2004) 56-63